Although aplykurodin A exhibited cytotoxic effect against HCC cells at high concentration, it is likely to be development into chemopreventive or therapeutic agent against CRT-positive cancers caused by AXIN1 mutation. The gene discussed is AXIN1; the disease is cancer.